DK2089047T3 - Sammensætninger og fremgangsmåder til beskyttelse og regenerering af hjerte-væv - Google Patents

Sammensætninger og fremgangsmåder til beskyttelse og regenerering af hjerte-væv

Info

Publication number
DK2089047T3
DK2089047T3 DK07867700.2T DK07867700T DK2089047T3 DK 2089047 T3 DK2089047 T3 DK 2089047T3 DK 07867700 T DK07867700 T DK 07867700T DK 2089047 T3 DK2089047 T3 DK 2089047T3
Authority
DK
Denmark
Prior art keywords
protecting
compositions
methods
cardiac tissues
regenerating cardiac
Prior art date
Application number
DK07867700.2T
Other languages
English (en)
Inventor
Lisa Spirio
Zen Chu
Original Assignee
3D Matrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3D Matrix Inc filed Critical 3D Matrix Inc
Application granted granted Critical
Publication of DK2089047T3 publication Critical patent/DK2089047T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK07867700.2T 2006-12-11 2007-12-11 Sammensætninger og fremgangsmåder til beskyttelse og regenerering af hjerte-væv DK2089047T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86943706P 2006-12-11 2006-12-11
PCT/US2007/025271 WO2008073395A2 (en) 2006-12-11 2007-12-11 Compositions and methods for cardiac tissue protection and regeneration

Publications (1)

Publication Number Publication Date
DK2089047T3 true DK2089047T3 (da) 2013-02-18

Family

ID=39183217

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07867700.2T DK2089047T3 (da) 2006-12-11 2007-12-11 Sammensætninger og fremgangsmåder til beskyttelse og regenerering af hjerte-væv

Country Status (6)

Country Link
US (2) US9012404B2 (da)
EP (1) EP2089047B1 (da)
JP (3) JP5558104B2 (da)
DK (1) DK2089047T3 (da)
ES (1) ES2400294T3 (da)
WO (2) WO2008073392A2 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1843776A4 (en) * 2004-07-06 2011-05-11 3D Matrix Inc PURIFIED AMPHILIC PEPTIDE COMPOSITIONS AND ITS USE
ES2534770T3 (es) * 2007-12-05 2015-04-28 3-D Matrix, Ltd. Material para la curación de heridas y la reconstrucción de la piel
RU2011118341A (ru) 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) Агент для окклюзии тканей
MX2011007854A (es) * 2009-01-26 2011-08-15 Univ California Metodos para tratar infartos agudos al miocardio y trastornos relacionados.
US20110117195A1 (en) * 2009-11-18 2011-05-19 National Cheng Kung University Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers
ES2653667T3 (es) * 2011-09-02 2018-02-08 3-D Matrix, Ltd. Péptidos anfifílicos para la oclusión del escape de aire torácico
US10905708B2 (en) 2011-09-07 2021-02-02 3-D Matrix, Ltd. MicroRNA-based methods and assays for osteocarcinoma
US11260072B2 (en) 2011-09-07 2022-03-01 3-D Matrix, Ltd. MicroRNA-based methods and assays for osteocarcinoma
EP2869903B1 (en) 2012-07-06 2018-11-28 3-D Matrix Ltd. Fill-finish process for peptide solutions
JP2015021582A (ja) 2013-07-22 2015-02-02 株式会社ジェイテクト 円錐ころ軸受と円錐ころ軸受を用いた動力伝達装置
JP6545727B2 (ja) 2014-03-10 2019-07-17 株式会社スリー・ディー・マトリックス 肺大気胞を治療するための自発組織化ペプチド
EP3116896B1 (en) 2014-03-10 2018-12-19 3-D Matrix Ltd. Self-assembling peptide compositions
ES2927887T3 (es) 2014-03-10 2022-11-11 3 D Matrix Ltd Esterilización de composiciones peptídicas
DE102015000363A1 (de) 2015-01-20 2016-07-21 Emc Microcollections Gmbh Neue modular funktionalisierbare Peptid-Hydrogele
US10702606B2 (en) 2015-12-10 2020-07-07 Menicon Co., Ltd. Peptide composition
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
WO2019116092A1 (en) 2017-12-15 2019-06-20 3-D Matrix, Ltd. Surfactant peptide nanostructures and uses in drug delivery
JP7442196B2 (ja) 2018-07-03 2024-03-04 株式会社スリー・ディー・マトリックス イオン性自己組織化ペプチド

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
CN1635885A (zh) * 2000-07-06 2005-07-06 惠氏公司 应用取代吲哚化合物增强一氧化氮合酶活性
US7449180B2 (en) * 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
US20040242469A1 (en) 2002-05-13 2004-12-02 Lee Richard T. Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
MXPA05007559A (es) * 2003-01-16 2005-09-21 Boehringer Ingelheim Int Combinacion farmaceutica para la prevencion o la terapia de enfermedades cardiovasculares, cardiopulmonares, pulmonares o renales.
US7713923B2 (en) * 2003-06-25 2010-05-11 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
EP2711025A3 (en) * 2003-06-25 2014-09-10 Massachusetts Institute of Technology Self-assembling peptides incorporating modifications and methods of use thereof
JP4813771B2 (ja) * 2004-04-14 2011-11-09 丸善製薬株式会社 血管内皮型一酸化窒素合成酵素活性促進剤
EP1843776A4 (en) 2004-07-06 2011-05-11 3D Matrix Inc PURIFIED AMPHILIC PEPTIDE COMPOSITIONS AND ITS USE
JP4949661B2 (ja) * 2004-09-21 2012-06-13 第一三共株式会社 ＨＭＧ−ＣｏＡリダクターゼ阻害剤とグルタチオンを含有する医薬組成物
AU2005323062A1 (en) * 2005-01-04 2006-07-13 The Brigham And Women's Hospital, Inc. Sustained delivery of PDGF using self-assembling peptide nanofibers
CA2609656C (en) * 2005-04-25 2016-02-02 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities

Also Published As

Publication number Publication date
ES2400294T3 (es) 2013-04-08
JP5903068B2 (ja) 2016-04-13
EP2089047A2 (en) 2009-08-19
EP2089047B1 (en) 2012-11-14
JP2013151560A (ja) 2013-08-08
US20150258166A1 (en) 2015-09-17
JP5558104B2 (ja) 2014-07-23
WO2008073392A2 (en) 2008-06-19
WO2008073392A3 (en) 2008-12-18
US9012404B2 (en) 2015-04-21
JP2010512393A (ja) 2010-04-22
WO2008073395A3 (en) 2008-11-06
WO2008073395A2 (en) 2008-06-19
JP2016033147A (ja) 2016-03-10
US20100143504A1 (en) 2010-06-10

Similar Documents

Publication Publication Date Title
DK2089047T3 (da) Sammensætninger og fremgangsmåder til beskyttelse og regenerering af hjerte-væv
NO20200670A1 (no) Sammensetninger og fremgangsmåter for modulering av hemostase
DK2001611T3 (da) Fremgangsmåde og sammensætning til oprensning af jord
DK3263589T5 (da) Peptidsekvenser og sammensætninger
DK2087002T3 (da) Sammensætninger og fremgangsmåder til binding af sphingosin-1-phosphat
DK2010501T3 (da) Imidazolbaserede forbindelser, sammensætninger omfattende disse og fremgangsmåder for deres anvendelse
DK2222675T3 (da) 5-anilinoimidazopyridiner og fremgangsmåder til deres anvendelse
DK1996557T3 (da) Pyridazinon-forbindelse og anvendelse deraf som herbicid
DK1827412T3 (da) Sammensætninger til anvendelse i kirurgi
EP2001998A4 (en) METHOD AND COMPOSITIONS FOR REPAIR BZW. REGENERATION OF DAMAGED HEART MUSCLES
DK2155188T3 (da) Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft
DK2894165T3 (da) Fremgangsmåder og sammensætninger til behandling af komplementforbundne forstyrrelser
DK2069312T3 (da) Pyridazinonderivater
CR10667A (es) Compositions and methods for diagnosing and treating cancer
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK2653873T3 (da) Sammensætninger og anvendelser til behandling af multipel sklerose
DK2061561T3 (da) Sammensætninger til behandling af cancer
FR2908035B1 (fr) Implant interepineux
DE602007000304D1 (de) Schützende und regenerierende Zusammensetzung
EP2064300A4 (en) ADHESIVE FABRIC COMPOSITIONS AND RELATED METHODS
DK2069467T3 (da) Adskillende sammensætninger og fremgangsmåder til anvendelse
DK3263112T3 (da) Sammensætninger og fremgangsmåder til undertrykkelse af endometriproliferationer
DK2125788T3 (da) Heterocykliske forbindelser, sammensætninger indeholdende dem og fremgangsmåder til deres anvendelse
FI20061029A (fi) Hammashoitolaitteisto
DK2146742T3 (da) Cellelinjer, sammensætninger omfattende disse til behandling af melanomer, fremgangsmåder til at fremstille sammensætningerne og behandlingsmetoder